Skip to main content
Premium Trial:

Request an Annual Quote

TransDerm Looks Past RNAi for Next Clinical Candidate

Premium

TransDerm, a small biotech focused on developing a treatment for pachyonychia congenita (PC), has just kicked off a phase I trial of a new drug candidate designed to treat the rare skin condition.

However, while the company had been focused on using RNAi as foundation for its products, the new trial is testing a product based on sirolimus, a macrolide immunosuppressant commonly used to prevent organ rejection in transplant patients.

TransDerm's first candidate, the siRNA-based drug TD101, proved capable of treating the lesions caused by PC in a single-patient phase I trial in 2008, but administration of the therapy — injection via a standard hypodermic needle — proved too painful to make the approach viable.

TransDerm began developing a microneedle array that could deliver TD101 without the pain and had been planning to begin testing it in another clinical study. However, it appears that the company has opted to pursue a different therapeutic modality for its next clinical candidate in sirolimus, which is topically administered.

It is unclear why TransDerm has put its TD101 efforts on hold, and company officials were unavailable for comment. However, the agent was designed to target a specific genetic mutation that is only present in a fraction of PC patients — a limit to its use that may have prompted the move to a compound with a potentially broader spectrum of activity.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.